Satraplatin or active metabolite kills prostate cancer in vitro


Treatment of prostate cancer cells with satraplatin or its active metabolite resulted in the killing of tumor cells, according to a poster presented at the American Association for Cancer Research's Basic, Translational, and Clinical Advances in Prostate Cancer meeting.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.